Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome

Annals of the Rheumatic Diseases

Volumn 66, Issue 4, 2007, Pages 506-510

  Paran, Daphna ^a,b   Caspi, Dan ^b   Levartovsky, David ^b   Elkayam, Ori ^b   Kaufman, Ilana ^b   Litinsky, Irena ^b   Keren, Gad ^b   Koifman, Bella ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; HEART FUNCTION; HEART VENTRICLE CONTRACTION; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLE;

ADULT; AGE FACTORS; AGED; ANTIPHOSPHOLIPID SYNDROME; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR DYSFUNCTION;

EID: 34147195381     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.044073     Document Type: Article

References (26)

1. Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus-a 5-yr prospective study. Rheumatology 2004;43:1039-44.
2. Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1955-9.
3. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
4. Kao AH, Sabatine JM, Manzi S. Update on vascular disease in systemic lupus erythematosus. Curr Opin Rheumatol 2003;15:519-27.
5. Jara IJ, Medina G, Vera-Lastra O, Shoenfeld Y. Atherosclerosis and antiphospholipid syndrome. Clin Rev Allergy Immunol 2003;25:79- 88.
6. Meroni PL, Borghi MO, Raschi E, Ventura D, Sarzi Puttini PC, Atzeni F, et al. Inflammatory response and the endothelium. Thromb Res 2004;114:329-34.
7. Cervera R. Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res 2004;114:501-7.
8. D'Cruz D, Khamashta M, Hughes G. Pulmonary manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. Baltimore: Williams & Wilkins, 2002:663-83.
9. Paran D, Fireman E, Elkayam O. Pulmonary disease in systemic lupus erythematosus and the antiphospholipid syndrome. Autoimmunity Rev 2004;3:70-5.
10. Kao AH, Manzi S. How to manage patients with cardiopulmonary disease? Best Pract Res Clin Rheumatol 2002;16:211-27.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
14. Tekfonidou MG, Ioannidis JPA, Moyssakis I, Boki KA, Vassiliou V, Vlachoyiannopoulos PG, et al. Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome. Ann Rheum Dis 2001;60:43-8.
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-4.
16. Glodman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000;2:373-6.
17. Duncan DB. T-tests and intervals for comparisons suggested by the data. Biometrics 1975;31:339-59.
18. Cacciapuoti F, Galzerno D, Capogrosso P, Arciello A, Liberti D, Cacciapuoti F, et al. Impairment of left ventricular function in systemic lupus erythematosus evaluated by measuring myocardial performance index with tissue Doppler echocardiography. Echocardiography 2005;22:315-19.
19. Gazarian M, Feldman BM, Benson LN, Gilday DL, Laxer RM, Silver ED. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 1998;132:109-16.
20. Crozier IG, Li E, Milne MJ, Nicholls M. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990;65:1145-8.
21. Bahl VK, Aradhye S, Vasan RS, Malhotra A, Reddy KS, Malaviya AN. Myocardial systolic function in systemic lupus eryihematosus: a study based on radionudide ventriculography. Clin Cardiol 1992;15:433-5.
22. Winslow TM, Ossipov MA, Fazio GP, Foster E, Simonson JS, Schiller NB. The left ventricle in systemic lupus erythematosus: initial observations and a five year follow up in a university medical center population. Am Heart J 1993;125:1117-22.
23. Giunta A, Picillo U, Maione S, Migliaresi S, Valentini G, Arnese M, et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-Doppler observations and immunological investigation. Acta Cardiol 1993;48:183-97.
24. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antipnospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-19.
25. Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Ugalde J, Aguirre C. Antiphospholipid antibodies predict early damage in patients with systemic lupus eryihematosus. Lupus 2004;13:900-5.
26. Laskin CA, Clark CA, Spitzer KA. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts? Rheum Dis Clin North Am 2005;2:255-72.